Ebo D G, Verweij M M, Sabato V, Hagendorens M M, Bridts C H, De Clerck L S
Faculty of Medicine, Department of Immunology, Allergology, Rheumatology, University of Antwerp, Antwerpen, Belgium.
Acta Clin Belg. 2012 Sep-Oct;67(5):317-21. doi: 10.2143/ACB.67.5.2062683.
Hazelnut (Corylus avellana) allergy varies from rather mild oral allergy symptoms to potentially life-threatening anaphylaxis and exhibits geographic and age-related variations. Severity of symptoms depends on the sensitisation profile of the patient and can partially be predicted using 'component-resolved diagnosis'. In our region (young) children predominantly exhibit sensitisation to hazelnut storage proteins Cor a 9 and Cor a 11 that is unrelated to birch pollen allergy and is generally associated with a more severe clinical outcome on consumption on raw and processed hazelnut. In contrast, adults predominantly present with an oral allergy syndrome due to an extensive cross-reactivity between the labile Cor a 1.04 and Bet v 1, the major allergen from birch (Betula verrucosa) pollen. In the absence of a cure, avoidance remains the key measure of effective management, particularly in those patients presenting with a severe form.
榛子(欧洲榛)过敏症状轻重不一,从较为轻微的口腔过敏症状到可能危及生命的过敏反应,且存在地域和年龄相关的差异。症状的严重程度取决于患者的致敏情况,部分可通过“组分分辨诊断”进行预测。在我们所在地区,(幼)儿童主要对榛子储存蛋白Cor a 9和Cor a 11致敏,这与桦树花粉过敏无关,通常在食用生榛子和加工榛子时会导致更严重的临床后果。相比之下,成年人主要表现为口腔过敏综合征,这是由于不稳定的Cor a 1.04与桦树(疣皮桦)花粉的主要过敏原Bet v 1之间存在广泛的交叉反应。由于无法治愈,避免接触仍是有效管理的关键措施,尤其是对于那些症状严重的患者。